Meeting Overview:
CTTI and the FDA held this workshop in order to:

• Seek ideas for best practices and key considerations for enhancing the incorporation of patient perspectives on clinical trial access, design, conduct, and post-trial follow-up
• Gather input from patients, caregivers, industry, academic researchers, and expert practitioners on the challenges and barriers to patient participation in clinical trials

You can watch the event, session by session:

• Session I: Enhancing Awareness and Access
• Session II: Design & Conduct of Patient-Centric Trials
• Session III: Post-Trial Communication & Engagement
• Recapping Key Themes & Looking Forward

A published report on proceedings and recommendations from the workshop, as well as session by session clips, are forthcoming.

Meeting Materials:

Meeting Agenda

Meeting Summary

Full Presentation Set

Session I: Enhancing Awareness and Access

• Enhancing Awareness and Access - Nancy Roach, Fight Colorectal Cancer
• Reaching, Educating and Engaging Diverse Communities: All of Us Research Program Case Study - Ronnie Tepp, All of Us Research Program

Session II: Design & Conduct of Patient-Centric Trials

• Patient Protocol Engagement Toolkit and the Study Participant Feedback Questionnaire - Mary Elmer, TransCelerate BioPharma Patient Experience Initiative
• Design of Patient Centric Trials - Case Examples: CoDESIGN - Eli Lilly and Company - Joseph Kim, Eli Lilly

Session III: Post-Trial Communication & Engagement

• Return of Results Aggregate and Individual - Jessica Scott, Takeda, and David Leventhal, Pfizer